PhenomeX Inc. Common Stock
CELL
CELL was delisted on the 29th of September, 2023.
102 hedge funds and large institutions have $63.3M invested in PhenomeX Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 37 reducing their positions, and 28 closing their positions.
345% more call options, than puts
Call options by funds: $49K | Put options by funds: $11K
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
13% less funds holding
Funds holding: 117 → 102 (-15)
14% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 37
50% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 28
51% less capital invested
Capital invested by funds: $130M → $63.3M (-$66.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NV
Northpond Ventures
Bethesda,
Maryland
|
+$9.85M |
| 2 |
PA
Perceptive Advisors
New York
|
+$4.58M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.62M |
| 4 |
GCM
Glenview Capital Management
New York
|
+$2.2M |
| 5 |
NIMC
Nierenberg Investment Management Company
Camas,
Washington
|
+$1.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.6M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.56M |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.63M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.36M |
| 5 |
Millennium Management
New York
|
-$1.21M |
CELL Hedge Fund Activity: Q1 2023 in Review
102 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in PhenomeX Inc. Common Stock (CELL) for Q1 2023, worth a combined $63.3M — down 51% from $130M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of CELL and 14 opened new positions — a net loss of 14 holders — while 37 trimmed existing stakes and 32 added.
The largest buyer was Northpond Ventures, opening a new position worth an estimated $9.85M. The largest seller was Federated Hermes, cutting an estimated $3.6M.
- 102 institutional investors held PhenomeX Inc. Common Stock (CELL) as of Q1 2023, down from 117 in Q4 2022.
- Funds reported $63.3M of PhenomeX Inc. Common Stock stock for Q1 2023, down 51% quarter-over-quarter.
- 14 funds opened new PhenomeX Inc. Common Stock positions in Q1 2023 and 28 closed out, a net change of -14 holders.
- The largest PhenomeX Inc. Common Stock buyer in Q1 2023 was Northpond Ventures, an estimated $9.85M added.
- The largest PhenomeX Inc. Common Stock seller in Q1 2023 was Federated Hermes, an estimated $3.6M sold.
Based on aggregated 13F filings for Q1 2023.